RYR1 and hyperinsulinemic hypoglycemia, familial, 4: Collectively, these results warrant prospective exploration of systemic NAD+ deficiency in RYR1-RM and, if replicated, could support a potential therapeutic approach of NAD+ repletion in those with baseline deficiency.